Jesús Molina

TL;DR: The original severity classification has been replaced by a much simpler risk classification (low or high risk), on the basis of lung function, dyspnea grade, and history of exacerbations, while determination of clinical phenotype is recommended only in high-risk patients.

TL;DR: The severity classification and the pharmacological treatment of stable COPD are described and GesEPOC is a new, more individualized approach to COPD treatment according to the clinical characteristics of the patients.

TL;DR: This research presents a meta-anatomy of the neumologia and physiology of the connective tissue of the autonomic nervous system, which has been studied in detail in the context of chronic illness and rehabilitation.

TL;DR: The severity classification and the pharmacological treatment of stable COPD are described and GesEPOC is a new, more individualized approach to COPD treatment according to the clinical characteristics of the patients.

TL;DR: The study showed that asthma exacerbations are costly to manage, suggesting that therapies able to increase asthma control and reduce the frequency or severity of exacerbations may bring economic benefits, as well as improved quality of life.